Pulmonary arterial hypertension (PAH) is a rare disease characterised by pulmonary
vascular remodelling and elevated pulmonary pressure, which eventually leads to right …

Anticoagulant-associated heavy menstrual bleeding (HMB) is an underrecognized but not
uncommon problem in clinical practice. Premenopausal women should be advised of the …

Preliminary data and clinical experience have suggested an increased risk of abnormal
uterine bleeding (AUB) in women of reproductive age treated with anticoagulants, but solid …

Background In this prospective cohort study, we aimed to evaluate the efficacy and safety of
direct oral anticoagulants (DOACs) versus heparin/vitamin K antagonists for the treatment of …

Abnormal vaginal bleeding can complicate direct oral anticoagulant (DOAC) treatment. We
aimed to investigate the characteristics of abnormal vaginal bleeding in patients with venous …

Essentials• Factor Xa inhibitors cause more abnormal menstrual bleeding (AUB) than
vitamin‐K antagonists (VKA).• We analyzed data of AUB in women, evaluating dabigatran …

Anticoagulants increase the risk of heavy menstrual bleeding (HMB). We sought to
investigate the incidence, predictors and management of HMB in women on rivaroxaban …

Background Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular dysplasia
resulting in visceral arteriovenous malformations and smaller mucocutaneous …

Background Observational data and results from post-hoc analyses in clinical trials suggest
that direct oral factor Xa inhibitors might increase menstrual bleeding intensity in women of …

Background There is increasing recognition that menstruating women prescribed
anticoagulants experience heavy menstrual bleeding. Objectives The aim of this study is to …